Moderna (MRNA) share buybacks: $2M
Moderna spent $2M buying back its own shares in the year ended Dec 31, 2025.
From Moderna's filings with the SEC · Read the filing · MRNA stock page
Moderna share buybacks by year
#1,641 of 1,890 US companies by share buybacks · See the full ranking
| Year ended | Share buybacks | Change |
|---|---|---|
| Dec 31, 2025 | $2M | -100% |
| Dec 31, 2023 | $1.2B | -65% |
| Dec 31, 2022 | $3.3B | +288% |
| Dec 31, 2021 | $857M | – |
Share buybacks of similar companies
Companies in the same industry as Moderna, by SEC industry code, with the closest share buybacks. Each name opens the same page for that company.
| Company | Share buybacks, latest year | Year ended |
|---|---|---|
| Exelixis | $948M | Jan 2, 2026 |
| Halozyme Therapeutics | $342M | Dec 31, 2025 |
| Qiagen | $280M | Dec 31, 2025 |
| Neurocrine Biosciences | $168M | Dec 31, 2025 |
| BIO-TECHNE | $41.7M | Jun 30, 2026 |
| ADMA Biologics | $31.9M | Dec 31, 2025 |
| Moderna | $2M | Dec 31, 2025 |
Questions and answers
What is Moderna's share buybacks?
Moderna spent $2M buying back its own shares in the year ended Dec 31, 2025.
Numbers as reported in Moderna's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology